---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-091891"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2025-07-01T23:59:59+00:00"
generated_at: "2026-05-18T10:25:59.953977+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Armistice exercises remaining 54,000 pre-funded warrants; all warrants now fully exercised

## Summary
- On June 18, 2025, Armistice Capital Master Fund exercised Pre-Funded Warrants for 54,000 shares of HCW Biologics common stock.
- With this exercise, all 513,140 Pre-Funded Warrants originally granted are fully exercised and none remain outstanding.
- Exercise price was $0.0001 per share, with negligible cash proceeds to the Company.

## SEC filing metadata
- accession: 0000950170-25-091891
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2025-07-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000095017025091891/0000950170-25-091891-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000095017025091891/hcwb-20250618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-091891
- JSON: https://secwatch.observer/filing/0000950170-25-091891.json
- Plain text: https://secwatch.observer/filing/0000950170-25-091891.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.